The Management of Hypogonadism in Aging Male Patients

被引:4
|
作者
Sharma, Vishwamitra [1 ]
Perros, Petros [2 ]
机构
[1] Luton & Dunstable Hosp, Luton, Beds, England
[2] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
关键词
hypogonadism; androgen deficiency; testosterone deficiency; testosterone replacement therapy; andropause; HORMONE-BINDING GLOBULIN; TESTOSTERONE-REPLACEMENT THERAPY; SYMPTOMATIC ANDROGEN DEFICIENCY; LEAN BODY-MASS; OLDER MEN; METABOLIC SYNDROME; ELDERLY-MEN; ERECTILE DYSFUNCTION; SERUM TESTOSTERONE; MUSCLE STRENGTH;
D O I
10.3810/pgm.2009.01.1960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article focuses on the evaluation and management of hypogonadism in aging male patients in the light of recent guidelines. The benefits of treating severe hypogonadism resulting from identifiable pituitary or primary gonadal disease are well established. Milder forms of hypogonadism in the aging male, known as andropause, are common, and constitute an expanding area of clinical interest and research. Several studies indicate that testosterone replacement therapy may produce a wide range of benefits for men with hypogonadism, including improvement in libido, bone density, muscle mass, body composition, mood, and cognition. Currently available data are insufficient to permit a definitive verdict on the balance between risks and benefits of testosterone replacement therapy in aging males.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 50 条
  • [1] Editorial: Aging and male hypogonadism
    Xia, Kai
    Yu, Jiajie
    Liu, Guihua
    Chen, Haolin
    Ge, Renshan
    Deng, Chunhua
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [2] LOH (late-onset hypogonadism) or the "aging male" [LOH (late onset hypogonadism) oder "aging male"]
    Sperling H.
    Jockenhövel F.
    Stackl W.
    Köhn F.-M.
    Ludwig G.
    Der Urologe, 2006, 45 (Suppl 4): : 163 - 168
  • [3] Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male
    Ahmed, Kamran
    Hatzimouratidis, Kostas
    Muneer, Asif
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 514 - 516
  • [4] Adjunct Management of Male Hypogonadism
    Bach P.V.
    Najari B.B.
    Kashanian J.A.
    Current Sexual Health Reports, 2016, 8 (4) : 231 - 239
  • [5] Management of male hypogonadotrophic hypogonadism
    Howles, Colin M.
    Tanaka, Toshiaki
    Matsuda, Tadashi
    ENDOCRINE JOURNAL, 2007, 54 (02) : 177 - 190
  • [6] MANAGEMENT OF MALE HYPERPROLACTINEMIC HYPOGONADISM
    HSU, TH
    HSU, SH
    BIAS, WB
    TYSON, JE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 275 (02): : 203 - 208
  • [7] Hypogonadism in male cancer patients
    Burney, Basil O.
    Garcia, Jose M.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2012, 3 (03) : 149 - 155
  • [8] HYPOGONADISM IN MALE PATIENTS AND HEMODIALYSIS
    Cedres, S.
    Valino, J.
    Campea, G.
    Dufrechou, C.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 69 - 69
  • [9] Hypogonadism in male patients with cancer
    Garcia, Jose M.
    Li, Huiling
    Mann, Douglas
    Epner, Daniel
    Hayes, Teresa G.
    Marcelli, Marco
    Cunningham, Glenn R.
    CANCER, 2006, 106 (12) : 2583 - 2591
  • [10] Male hypogonadism: pathogenesis, diagnosis, and management
    Silva, Nipun Lakshitha De
    Papanikolaou, Nikoleta
    Grossmann, Mathis
    Antonio, Leen
    Quinton, Richard
    Anawalt, Bradley David
    Jayasena, Channa N.
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (10): : 761 - 774